Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous silymarin around liver transplantation for prevention of HCV graft reinfection
2012-001457-50Phase 2Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Legalon SIL in hepatitis C virus infection, sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoint: HCV RNA. Started Apr 2012; status: active.
02
Drugs
Legalon SIL
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2012-001457-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001457-50.